[Federal Register Volume 69, Number 197 (Wednesday, October 13, 2004)]
[Rules and Regulations]
[Page 60811]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-22915]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 510


New Animal Drugs; Change of Sponsors' Addresses

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
drug regulations to reflect changes of address for Alpharma Inc.; 
Intervet Inc.; and V[egrave]toquinol N.-A., Inc.

DATES: This rule is effective October 13, 2004.

FOR FURTHER INFORMATION CONTACT: David R. Newkirk, Center for 
Veterinary Medicine (HFV-100), Food and Drug Administration, 7500 
Standish Pl., Rockville, MD 20855, 301-827-6967; e-mail: 
[email protected].

SUPPLEMENTARY INFORMATION: Alpharma Inc., One Executive Dr., P.O. Box 
1399, Fort Lee, NJ 07024, has informed FDA of a change of address to 
One Executive Dr., Fort Lee, NJ 07024. Intervet, Inc., P.O. Box 318, 
405 State St., Millsboro, DE 19966, has informed FDA of a change of 
address to 29160 Intervet Lane, P.O. Box 318, Millsboro, DE 19966. 
V[egrave]toquinol N.-A., Inc., 2000 chemin Georges, Lavaltrie (PQ), 
Canada J0K 1H0, has informed FDA of a change of address to 2000 chemin 
Georges, Lavaltrie (PQ), Canada J5T 3S5. Accordingly, the agency is 
amending the regulations in 21 CFR 510.600 to reflect these changes of 
sponsors' addresses.
    This rule does not meet the definition of ``rule'' in 5 U.S.C. 
804(3)(A), because it is a rule of ``particular applicability.'' 
Therefore, it is not subject to congressional review requirements in 5 
U.S.C. 801-808.

List of Subjects in 21 CFR Part 510

    Administrative practice and procedure, Animal drugs, Labeling, 
Reporting and recordkeeping requirements.

0
Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
authority delegated to the Commissioner of Food and Drugs and 
redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is 
amended as follows:

PART 510--NEW ANIMAL DRUGS

0
1. The authority citation for 21 CFR part 510 continues to read as 
follows:

    Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.


Sec.  510.600  [Amended]

0
2. Section 510.600 is amended:
    a. In the table in paragraph (c)(1) in the entry for ``Alpharma 
Inc.'', by removing ``P.O. Box 1399,'';
    b. In the table in paragraph (c)(1) in the entry for ``Intervet, 
Inc.'', by removing ``Intervet, Inc., P.O. Box 318, 405 State St.'' and 
by adding in its place ``Intervet Inc., P.O. Box 318, 29160 Intervet 
Lane'';
    c. In the table in paragraph (c)(1) in the entry for 
``V[egrave]toquinol N.-A., Inc.'', by removing ``J0K 1H0'' and by 
adding in its place ``J5T 3S5'';
    d. In the table in paragraph (c)(2) in the entry for ``046573'', by 
removing ``P.O. Box 1399'';
    e. In the table in paragraph (c)(2) in the entry for ``057926'' by 
removing ``Intervet, Inc., P.O. Box 318, 405 State St.'' and by adding 
in its place ``Intervet Inc., P.O. Box 318, 29160 Intervet Lane''; and
    f. In the table in paragraph (c)(2) in the entry for ``059320'', by 
removing ``J0K 1H0'' and by adding in its place ``J5T 3S5''.

    Dated: September 16, 2004.
Bernadette A. Dunham,
Deputy Director, Office of New Animal Drug Evaluation, Center for 
Veterinary Medicine.
[FR Doc. 04-22915 Filed 10-12-04; 8:45 am]
BILLING CODE 4160-01-S